
Qnovia Announces First Human Trial Results, Under FDA and MHRA Review
Key points: Pharmaceutical manufacturer Qnovia has announced the first human trial results for its inhaled smoking cessation therapy QN-01, which is currently under review by the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Resea






